“…Over the years we have successfully deployed this protocol using live and intact blood or marrow cells, such as those aimed at the study of healthy and pathological hematopoietic stem cells ( Fornas et al., 2000 ), erythroid differentiation ( Fornas et al., 2002 ), oxidative burst and neutrophil-platelet complexes ( Avendaño et al., 2008 ), phagocytosis ( Lecube et al., 2011 ), enzymatic activity ( Rico et al., 2016 , 2019 ; Bardina et al., 2020 ), reactive oxygen species production ( Cossarizza et al., 2019 ), cell-mediated cytotoxicity ( Rico et al., 2021a ), or to the study changes in conformation of the extracellular domain of PD-L1 ( Rico et al., 2021b ).…”